The women’s health and wellness space is booming. The opportunities are real and so are the rewards. This is where you keep up. Welcome to The DXF Edit.
MONEY MOVES
AI Just Got $1 Million to Fight the Cancer That Kills Women Quietly
Despite being the deadliest gynecologic cancer in the US, ovarian cancer research funding still lags far behind diseases with substantially better survival odds.
The Global Ovarian Cancer Research Consortium announced its second $1 million AI Accelerator Grant on World Ovarian Cancer Day, backed by AWS cloud infrastructure. The grant targets data-driven early detection research in a cancer that kills more than 200,000 women globally each year, almost entirely because it’s caught too late.
The survival gap is not ambiguous:
- 90%+ five-year survival rate when caught early
- Fewer than 20% of cases are caught early
That gap exists in part because the research funding to close it never materialized. The NCI has historically spent nearly 19 times more per person-year of life lost on prostate cancer than on ovarian cancer. A million dollars from a private consortium is meaningful precisely because the federal baseline has been so low, and because NIH cuts in 2025 and 2026 have made private grants more load-bearing than they should be.
One million dollars for a cancer this deadly isn’t generosity. It’s an indictment of every funding decision that came before it.
Fertility Care Is Moving Into Your OB/GYN’s Office, and That’s the Point
Infertility affects an estimated 10 million women in the United States. Fewer than 1% ever reach a specialized fertility center.
On May 5, Femasys announced the first revenue-generating commercial use of its FemaSeed Complete system in an OB/GYN office, a milestone that matters less for the company’s balance sheet and more for what it represents structurally. FemaSeed is an intratubal insemination device designed as a first-line fertility treatment, supported by FemSperm for in-office sperm preparation. Clinical data show it delivers more than double the pregnancy rate of traditional IUI.
The access gap in fertility care isn’t just clinical, it’s logistical and financial. Specialized fertility centers are expensive, geographically concentrated, and the only referral destination most women ever get. Moving first-line treatment into the OB/GYN office means earlier intervention, lower cost, and a care pathway that doesn’t require a specialist most women can’t reach or afford.
The question now is whether OB/GYNs adopt it at scale, and whether insurers follow. If they do, the 99% who never made it to a specialist finally have a first move.
INNOVATION
PCOS Is Dead. PMOS Is What We Should Have Been Talking About All Along.
For 90 years, medicine named a complex hormonal and metabolic condition after ovarian cysts, structures that aren’t actually cysts, aren’t always present, and were never the point. Women who didn’t present with them were dismissed. Sent home on birth control. Told to lose weight. Told to come back when they wanted children.
On May 12, a global consensus published in The Lancet officially renamed it polyendocrine metabolic ovarian syndrome — PMOS. Eleven years. 22,000 stakeholders. The new name reflects what the condition actually is: a multisystem endocrine and metabolic disorder affecting 170 million women worldwide, 70% of whom are currently undiagnosed.
The rename isn’t just symbolic. Clinicians can now diagnose on hormonal and metabolic markers alone, no ultrasound required. The diagnostic question shifts from “do you have cysts?” to “what are your hormones and metabolism actually doing?” That reorientation changes who gets caught, how early, and what gets treated, including the insulin resistance, cardiovascular risk, and depression that went unscreened for decades while everyone was looking at the ovaries.
What a name change can’t fix: the undertrained GPs, the research gaps, or the years of “just lose weight” that already happened. But getting the name right is where everything else starts.
The Postpartum Checkup Is at Six Weeks. The Deaths Are Happening Much Later.
The maternal health system was built around pregnancy. It largely stops there.
Around 600 women die every year in the US from cardiovascular causes tied to pregnancy. More than half of those deaths happen not in the delivery room, but in the months after, up to a full year postpartum. A new National Academies report says over 75% are preventable. The warning signs, hypertension, preeclampsia, gestational diabetes, were there during pregnancy. The follow-up care wasn’t.
Insurance lapses at 60 days. The handoff from OB to primary care is fragmented or never happens. The six-week checkup remains the standard, designed for an era when nobody was tracking what came next.
The fixes the report recommends aren’t complicated: remote blood pressure monitoring, continuous insurance coverage through the postpartum year, structured clinical follow-up. Every other high-income country already does this. Most guarantee a home visit within the first week.
The US sends new mothers home and books them for six weeks out. The gap between those two things is where 600 women a year disappear.
LAW & POLICY
The Supreme Court Is Running Out the Clock on Abortion Pill Access
This is not a resolution. It’s a countdown.
On May 11, the Supreme Court extended its temporary order keeping mifepristone available via telehealth and mail, but only through Thursday at 5 p.m. ET. The order responds to a 5th Circuit ruling that blocked the FDA’s rule allowing patients to access abortion pills without an in-person visit. Louisiana’s lawsuit, the engine behind the case, argues the Biden-era telehealth rule undermined its state abortion ban.
The stakes are not abstract:
- Medication abortion accounts for approximately two-thirds of all US abortions
- Roughly 25% of those happen via telemedicine
- If the 5th Circuit ruling stands, it marks the first nationwide restriction on abortion access since Dobbs
The pill itself isn’t the target. Access is. And access is what’s left when surgical options are gone. This case is being decided in 72-hour increments, and the clock is still running.
The South Finally Has Paid Family Leave. Virginia Just Changed the Map.
For working mothers in the South, “paid leave” has long meant whatever your employer felt like offering, which, for most, meant nothing.
On May 11, Governor Spanberger signed landmark legislation making Virginia the first Southern state to mandate paid family and medical leave. Starting December 2028, workers can take up to 12 weeks of paid leave, at 80% of wages, for a new child, a serious illness, caregiving responsibilities, or escaping domestic violence. Three million Virginia workers are now covered.
The women’s health implications are direct. Postpartum recovery, newborn bonding, and maternal mental health all require time that unpaid leave makes impossible for most working women. Domestic violence survivors, overwhelmingly women, now have a financial runway to leave without losing income. Caregivers, who are disproportionately women, no longer have to choose between a paycheck and a sick parent.
The rest of the South is watching. Twelve states now have paid leave laws — all outside the South. Virginia just broke that wall.
ON THE FEED
Get Pregnant, Lose Your Audience?
There’s a pattern playing out across fitness and wellness feeds right now, and nobody is quite ready to say what it is.
Female creators who’ve spent years building audiences around their health, their bodies, and their routines are announcing pregnancies and watching their follower counts drop in real time. Whitney Simmons was called “irresponsible” by her own community after her pregnancy announcement. Nelly Toledo lost 15,000 followers and brand deals overnight. Across TikTok and Instagram, creators are documenting the same experience, sometimes losing thousands of followers within 24 hours of the news.
The conversation is split. Some frame it as personal curation — they followed for specific content, not a life pivot. Others are sitting with something more uncomfortable: what does it say about the way we consume women online that the moment a woman’s body moves outside the aspirational frame, the audience exits?
These women didn’t change. The terms of the audience’s investment did.
The Government Spent This Week Posting Nutrition Tips. The Supreme Court Was Deciding Something Much Bigger.
National Women’s Health Week ran May 10–16. The theme was “Prevention, Innovation, and Impact.” The FDA launched a food label literacy campaign. The Office on Women’s Health posted about calcium, screenings, and self-care.
On May 11, the same week, the Supreme Court extended a temporary order keeping Mifepristone available via telehealth. Not because the question was settled. Because it needed 72 more hours to decide whether women could continue accessing abortion medication by mail.
Women on social media noticed. The stitches, the quote tweets, the dry commentary, the posts writing themselves. The government ran a wellness awareness campaign while a federal court decided the terms of reproductive access. The cognitive dissonance landed, and it landed loud.
Posting about nutrition while the Supreme Court deliberates abortion access isn’t a contradiction. It’s a pretty accurate summary of where things stand.
THIS WEEK’S SELECTION
Kitsch Satin Heatless Curling Set — $18 The overnight hair tool that completely took over “low-effort beauty” TikTok. Lets you wake up with styled hair without heat damage, which made it explode alongside the broader “maintenance beauty” trend.
LMNT Electrolytes — $23 (12-count variety pack) Zero sugar, no artificial dyes — 1000mg sodium, 200mg potassium, 60mg magnesium per stick pack. The electrolyte drink mix that’s dominated fitness and wellness feeds for two years running and still isn’t slowing down.
Glow Recipe Watermelon Glow Niacinamide Dew Drops — $34 The skincare-makeup hybrid that makes everyone ask what you’re doing differently. Niacinamide tackles hyperpigmentation and pores, watermelon extract hydrates, and the whole thing gives a glass-skin finish.
Naturium The Glow Getter Multi-Oil Body Wash — $16 Clinical-grade bodycare at drugstore price. An oil-to-foam formula with 50% glycerin, plant-derived squalane, and linoleic-rich oils that cleans without stripping.
Loop Quiet 2 Earplugs — $25 The most comfortable earplugs (from someone who CANNOT stand earplugs). Designed to reduce background noise without fully blocking sound, making them popular for sleep, focus, travel, and nervous-system regulation.